Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study.
Holdaas H, de Fijter JW, Cruzado JM, Massari P, Nashan B, Kanellis J, Witzke O, Gutierrez-Dalmau A, Turkmen A, Wang Z, Lopez P, Bernhardt P, Kochuparampil J, van der Giet M, Murbraech K; ELEVATE Study Group. Holdaas H, et al. Among authors: massari p. Transplantation. 2017 Oct;101(10):2612-2620. doi: 10.1097/TP.0000000000001739. Transplantation. 2017. PMID: 28333860 Clinical Trial.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: massari p. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
Results of the conversion to everolimus in renal transplant recipients with posttransplantation malignancies.
Chiurchiu C, Carreño CA, Schiavelli R, Petrone H, Balaguer C, Trimarchi H, Pujol GS, Novoa P, Acosta F, González C, Arriola M, Massari PU; Argentinian Registry of Everolimus Treated Renal Transplant Recipients. Chiurchiu C, et al. Among authors: massari pu. Transplant Proc. 2010 Jan-Feb;42(1):277-9. doi: 10.1016/j.transproceed.2009.11.017. Transplant Proc. 2010. PMID: 20172329
Renal transplantation in diabetic patients.
Bittar J, Cepeda P, de la Fuente J, Douthat W, de Arteaga J, Massari PU. Bittar J, et al. Among authors: massari pu. Transplant Proc. 2006 Apr;38(3):895-8. doi: 10.1016/j.transproceed.2006.02.054. Transplant Proc. 2006. PMID: 16647502
Renal transplantation in high cardiovascular risk patients.
Bittar J, Arenas P, Chiurchiu C, de la Fuente J, de Arteaga J, Douthat W, Massari PU. Bittar J, et al. Among authors: massari pu. Transplant Rev (Orlando). 2009 Oct;23(4):224-34. doi: 10.1016/j.trre.2009.02.001. Epub 2009 Jun 11. Transplant Rev (Orlando). 2009. PMID: 19520563 Review.
A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group.
Massari PU, Grosso S, de Boccardo G, Vásquez MC, Schiavelli RO, Sabbatiello RR, Casadei DH, Rial MC, Jost LJ, Túrin MD, Agost Carreño C A, Maggiora EC, Gadea MM. Massari PU, et al. Transplant Proc. 1996 Dec;28(6):3365-7. Transplant Proc. 1996. PMID: 8962310 Clinical Trial. No abstract available.
Renal transplantation and Chagas' disease.
de Arteaga J, Massari PU, Galli B, Garzón Maceda F, Zlocowsky JC. de Arteaga J, et al. Among authors: massari pu. Transplant Proc. 1992 Oct;24(5):1900-1. Transplant Proc. 1992. PMID: 1412905 No abstract available.
164 results